A double-blind trial of clonazepam in benign essential tremor

Clin Neuropharmacol. 1984;7(1):83-8. doi: 10.1097/00002826-198403000-00004.


Clonazepam has been reported to be of some value in the treatment of benign essential tremor in open trials. The efficacy of clonazepam was evaluated in a double-blind placebo-controlled study using up to 4 mg/day. By a variety of objective measures, clonazepam was not found to be an effective form of therapy.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Benzodiazepinones / therapeutic use*
  • Clinical Trials as Topic
  • Clonazepam / adverse effects
  • Clonazepam / therapeutic use*
  • Confusion / chemically induced
  • Double-Blind Method
  • Erectile Dysfunction / chemically induced
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tremor / drug therapy*


  • Benzodiazepinones
  • Clonazepam